Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

AI model nearly halves false positive rates for lung cancer CT screenings
Reducing false positives could decrease the frequency of unnecessary procedures, lower the associated costs and also ease patient anxiety concerning CT results.
AI for opportunistic osteoporosis screening inks FDA clearance
The tool analyzes routine hip and pelvis X-rays for signs of low bone mineral density.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Exploring the link between left ventricular diastolic function and AFib
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.

Many providers remain underinformed about increased cancer risks associated with breast density

JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.

Long-term lung cancer survival rates see a 'dramatic' boost thanks to early detection initiatives

When lung cancer is caught in its early stages, long-term survival rates can reach 80% and higher, according to a new large-scale, 20-year international study presented at this year's RSNA meeting.

New partnership seeks to streamline AI integration into lung cancer screening

A new partnership between Sirona Medical and RevealDX could streamline the process of AI integration into the clinical practice of lung nodule assessments.

The Nanox ARC cold-cathode, tomosythesis 3D X-ray system is currently pending FDA clearance. If cleared, it would be the first device of its kind to offer cold-cathode X-ray tube technology and the ability to slice through the anatomy in images similar to CT scans aid diagnosis. The new type of tube also could greatly reduce the size and weight of X-ray systems. The vendor sees this system as key to its larger plan to address health disparities and access to imaging world-wide. #Nanox

Can cold-cathode X-ray combined with teleradiology and AI eliminate health disparities?

The Israeli vendor Nanox says it has a vision for the future of healthcare. It seeks to address health disparities and access challenges with a new business model and innovative package of technologies. Hurdles loom, but opportunities abound.

Personalized breast cancer risk assessment could reduce overdiagnosis

Personalized breast cancer screening programs could help women better understand their personal cancer risks and guide providers in recommending mammographic assessments based on these risks.

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients.

Why some women tend to overestimate their breast cancer risks

For women with dense breasts, it can be particularly challenging to differentiate between actual and perceived breast cancer risks.

What factors influence low follow-up adherence after a positive LDCT cancer screening?

Experts are calling for strategies to improve follow-up adherence among individuals who have positive lung cancer screenings after a new analysis revealed low rates of compliance.

Screening

AI model nearly halves false positive rates for lung cancer CT screenings

AI for opportunistic osteoporosis screening inks FDA clearance

Emphysema on baseline lung cancer CT a sign of future mortality risk

Exploring the link between left ventricular diastolic function and AFib

Late-stage prostate cancer diagnoses on the rise